Noninvasive Prenatal Testing Market Volume Forecast and Value Chain Analysis 2016-2020
Noninvasive prenatal testing (NIPT) is also known as noninvasive prenatal diagnosis (NIPD) market. Non-invasive prenatal testing (NIPT) is used for screening pregnant women at high risk of developing fetal chromosomal aneuploidies such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome) or a sex chromosome irregularity, such as Turner syndrome. The testing can also be used to determine a baby's sex and rhesus (Rh) blood type. The Non-Invasive Prenatal Test (NIPT) is a DNA test...
View full press release